Early Superficial Temporal Artery to Middle Cerebral Artery Bypass in Acute Ischemic Stroke
Overview
Affiliations
Objective: To evaluate the effects and safety of superficial temporal artery-middle cerebral artery (STA-MCA) anastomosis in the early stage after an acute ischemic event and the improvement of present symptoms in patients with intracranial atherosclerotic occlusive disease with stroke/stroke in progress.
Methods: From 2006 to 2010, 20 patients (15 males and five females) with atherosclerotic cerebrovascular disease were treated with an STA-MCA bypass. All of the patients presented with an acute ischemic stroke or stroke in progress despite maximal medical treatment. The patients underwent an STA-MCA bypass within 7 days from symptom onset. The clinical outcome and hemodynamic study of the 20 patients were preoperatively and postoperatively investigated. A pooled analysis was performed, and the results were compared with those obtained from other delayed STA-MCA bypass studies.
Results: Among the 20 patients who underwent an early STA-MCA bypass, fourteen (70%) patients achieved a good functional outcome (mRS 0, n=3; mRS 1, n=9; mRS 2, n=2). Prior to surgery, the mean basal regional cerebral blood flow (rCBF) and cerebrovascular reserve capacity (CVR) in the symptomatic hemisphere were 37.3±4.3 ml/100 g/min and -1.68±2.9%. The mean basal rCBF and CVR had significantly increased postoperatively, and no reperfusion-induced hemorrhage had occurred. In the pooled analysis, no significant differences were observed in the clinical outcome (P=0.328) or in the incidence of postoperative complications (P=0.516) between patients who underwent an early STA-MCA bypass and in patients who underwent a delayed STA-MCA bypass in previous studies.
Conclusions: In this study, which consisted of 20 carefully selected patients with acute ischemic stroke, an early STA-MCA bypass was safely and effectively performed, and in some cases, an early STA-MCA bypass resulted in rapid neurological improvement. An early STA-MCA bypass was beneficial in select patients who had acute ischemic stroke with imaging evidence of a small infarction.
Choi J, Kim M, Park J, Ahn J, Kwun B, Park W Neurosurg Rev. 2024; 47(1):817.
PMID: 39443346 DOI: 10.1007/s10143-024-03051-2.
Guo L, Yang L, Li C, Zeng Y, Xu R, Wang Z Neurosurg Rev. 2024; 47(1):25.
PMID: 38163848 PMC: 10758367. DOI: 10.1007/s10143-023-02257-0.
Jo H, Lee S, Jeong H, Kim Y, Kim T, Sunwoo L Sci Rep. 2023; 13(1):3717.
PMID: 36879127 PMC: 9988922. DOI: 10.1038/s41598-023-30874-8.
Ponatinib-Induced Cerebrovascular Accident (CVA).
Azad F, Zhang J, Miranda C, Gravina M Cureus. 2023; 14(12):e32383.
PMID: 36632247 PMC: 9829188. DOI: 10.7759/cureus.32383.
Eun J, Park I J Korean Neurosurg Soc. 2022; 65(6):816-824.
PMID: 36069027 PMC: 9666234. DOI: 10.3340/jkns.2022.0100.